Explore a collection of noteworthy pharmaceutics articles that are helping shape modern medicine's landscape—and learn how to contribute your own pharmaceutics research to the journal.
Pharmaceutics is a fundamental, ever-evolving field within the chemical sciences. Pharmaceutical research is crucial for advancing drug targeting mechanisms, employing advanced chemistry techniques to develop delivery systems that can effectively navigate the complexities of the human body.
Within the ACS journal portfolio, ACS Pharmacology & Translational Science is a leading platform for groundbreaking research and discovery in pharmaceutics. To showcase the breadth of emerging innovations in this field, we have curated a selection of 10 noteworthy pharmaceutics articles recently published in the journal.
We hope you find this collection informative and useful in furthering your own knowledge and research. The ongoing explorations and developments shown in these articles demonstrate pharmaceutics’ indispensable role in revolutionizing drug delivery methods and shaping the landscape of modern medicine. If you are interested in submitting your own pharmaceutics research to ACS Pharmacology & Translational Science, click below to learn more about how to get started.
Craft of Co-encapsulation in Nanomedicine: A Struggle To Achieve Synergy through Reciprocity
Sourav Bhattacharjee*
ACS Pharmacol. Transl. Sci. 2022, 5, 5, 278–298
DOI: 10.1021/acsptsci.2c00033
ACS Pharmacol. Transl. Sci. 2022, 5, 5, 278–298
DOI: 10.1021/acsptsci.2c00033
Ranking Breast Cancer Drugs and Biomarkers Identification Using Machine Learning and Pharmacogenomics
Aamir Mehmood, Sadia Nawab, Yifan Jin, Hesham Hassan, Aman Chandra Kaushik*, and Dong-Qing Wei*
ACS Pharmacol. Transl. Sci. 2023, 6, 3, 399–409
DOI: 10.1021/acsptsci.2c00212
ACS Pharmacol. Transl. Sci. 2023, 6, 3, 399–409
DOI: 10.1021/acsptsci.2c00212
Druggability of Targets for Diagnostic Radiopharmaceuticals
Xinyu Wang*, Chongyang Chen, Junjie Yan, Yuping Xu, Donghui Pan, Lizhen Wang, and Min Yang*
ACS Pharmacol. Transl. Sci. 2023, 6, 8, 1107–1119
DOI: 10.1021/acsptsci.3c00081
ACS Pharmacol. Transl. Sci. 2023, 6, 8, 1107–1119
DOI: 10.1021/acsptsci.3c00081
Development of Inhaled GABAA Receptor Modulators to Improve Airway Function in Bronchoconstrictive Disorders
Nicolas M. Zahn, M. S. Rashid Roni, Gene T. Yocum, Michelle J. Meyer, Daniel A. Webb, Md Yeunus Mian, James M. Cook, Douglas C. Stafford, Charles W. Emala, and Leggy A. Arnold*
ACS Pharmacol. Transl. Sci. 2022, 5, 2, 80–88
DOI: 10.1021/acsptsci.1c00238
ACS Pharmacol. Transl. Sci. 2022, 5, 2, 80–88
DOI: 10.1021/acsptsci.1c00238
Hemopexin as a Potential Binding Partner of Arginine-Rich Cell-Penetrating Peptides in Serum
Kayo Nomura, Kenichi Kawano, Yoshimasa Kawaguchi, Yuki Kawamura, Junya Michibata, Keiko Kuwata, Koji Sugiyama, Kenji Kusumoto, and Shiroh Futaki*
ACS Pharmacol. Transl. Sci. 2022, 5, 8, 603–615
DOI: 10.1021/acsptsci.2c00043
ACS Pharmacol. Transl. Sci. 2022, 5, 8, 603–615
DOI: 10.1021/acsptsci.2c00043
Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor
Jens Glaser*, Ada Sedova, Stephanie Galanie, Daniel W. Kneller, Russell B. Davidson, Elvis Maradzike, Sara Del Galdo, Audrey Labbé, Darren J. Hsu, Rupesh Agarwal, Dmytro Bykov, Arnold Tharrington, Jerry M. Parks, Dayle M. A. Smith, Isabella Daidone, Leighton Coates, Andrey Kovalevsky, and Jeremy C. Smith*
ACS Pharmacol. Transl. Sci. 2022, 5, 4, 255–265
DOI: 10.1021/acsptsci.2c00026
ACS Pharmacol. Transl. Sci. 2022, 5, 4, 255–265
DOI: 10.1021/acsptsci.2c00026
Loading and Release of Quercetin from Contact-Drawn Polyvinyl Alcohol Fiber Scaffolds
Zachary B. Visser, Surendra Kumar Verma, Jan K. Rainey*, and John P. Frampton*
ACS Pharmacol. Transl. Sci. 2022, 5, 12, 1305–1317
DOI: 10.1021/acsptsci.2c00191
ACS Pharmacol. Transl. Sci. 2022, 5, 12, 1305–1317
DOI: 10.1021/acsptsci.2c00191
Pharmacokinetic Optimization of Small Molecule Janus Kinase 3 Inhibitors to Target Immune Cells
Julian Laux, Michael Forster, Laura Riexinger, Anna Schwamborn, Jamil Guezguez, Christina Pokoj, Mark Kudolo, Lena M. Berger, Stefan Knapp, Dieter Schollmeyer, Jan Guse, Michael Burnet, and Stefan A. Laufer*
ACS Pharmacol. Transl. Sci. 2022, 5, 8, 573–602
DOI: 10.1021/acsptsci.2c00054
ACS Pharmacol. Transl. Sci. 2022, 5, 8, 573–602
DOI: 10.1021/acsptsci.2c00054
Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation
Camilla Ruffilli, Sascha Roth, Monica Rodrigo, Helen Boyd, Noam Zelcer, and Kevin Moreau*
ACS Pharmacol. Transl. Sci. 2022, 5, 10, 849–858
DOI: 10.1021/acsptsci.2c00142
ACS Pharmacol. Transl. Sci. 2022, 5, 10, 849–858
DOI: 10.1021/acsptsci.2c00142
Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine
Mi Ho Jeong, Hongwei Han, David Lagares*, and Hyungsoon Im*
ACS Pharmacol. Transl. Sci. 2022, 5, 8, 520–538
DOI: 10.1021/acsptsci.2c00028
ACS Pharmacol. Transl. Sci. 2022, 5, 8, 520–538
DOI: 10.1021/acsptsci.2c00028
Want More from This Journal?
Stay Connected
Sign up today for email updates on the latest research, issues, and other content from ACS Pharmacology & Translational Science.
Information for Authors
Interested in submitting your research to ACS Pharmacology & Translational Science? Learn how to prepare and submit your manuscript, review publishing and editorial policies, and more.